Kaliumchlorid/Natriumchlorid B. Braun (Potassium Chloride, Sodium Chloride)

Kaliumchlorid/Natriumchlorid B. Braun is used to correct electrolyte imbalances and support fluid homeostasis in clinical settings.

• Hypokalemia: restores potassium levels to prevent cardiac arrhythmias.
• Hyponatremia: replenishes sodium to maintain plasma osmolality.
• Peri‑operative electrolyte replacement: ensures stable electrolyte concentrations during surgery.
• Critical‑care fluid management: maintains electrolyte balance in severely ill patients.

• The injection provides potassium and sodium ions that readily dissolve in plasma, increasing extracellular concentrations of these electrolytes. Elevated potassium corrects hypokalemia, while sodium restores osmotic balance and plasma volume. Together they help normalize membrane potentials and support cellular function across multiple organ systems.

Adverse reactions may occur with intravenous electrolyte administration.

Common Side Effects

• Infusion site pain or erythema.
• Mild hyperkalemia causing transient muscle weakness.
• Mild hypernatremia leading to thirst.
• Nausea or vomiting.
• Headache.
• Transient hypotension.

Serious or Rare Side Effects

• Cardiac arrhythmia due to severe hyperkalemia.
• Severe hypernatremia with neurologic impairment.
• Anaphylactic or severe allergic reaction.
• Vein thrombosis or phlebitis.
• Electrolyte‑induced seizures.
• Life‑threatening cardiac arrest.

When using Kaliumchlorid/Natriumchlorid B. Braun, clinicians should observe several safety measures.

• Monitor serum electrolytes: check potassium and sodium levels regularly.
• Adjust infusion rate: administer slowly to avoid rapid shifts.
• Renal impairment: use with caution and adjust dose as needed.
• Hyperkalemia contraindication: do not administer if serum potassium is already elevated.
• Avoid rapid bolus: prevent cardiac complications.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kaliumchlorid/Natriumchlorid B. Braun can interact with other medications that affect electrolyte balance.

Major Interactions (Avoid)

• ACE inhibitors or ARBs: may increase serum potassium.
• Potassium‑sparing diuretics (e.g., spironolactone): risk of hyperkalemia.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce renal potassium excretion.

Moderate Interactions (Monitor Closely)

• Digoxin: heightened risk of toxicity with altered potassium.
• Beta‑blockers: may mask symptoms of electrolyte disturbances.
• Concurrent IV electrolyte solutions: monitor total electrolyte load.